Tag: CMC

Addressing Inadequate Control Strategies During Pilot Scale Operations Inadequate control strategies during pilot scale operations can pose significant risks to pharmaceutical development. When these gaps are identified, they can result…

Managing Process Variability During Validation Planning: A Practical Playbook In the pharmaceutical manufacturing landscape, maintaining consistent and predictable processes is paramount, especially during validation planning. Process variability that exceeds established…

Tackling Process Variability During Validation Planning: A Practical Playbook In the complex landscape of pharmaceutical manufacturing, process variability can lead to significant challenges, particularly during validation planning. This article provides…

Strategies for Managing Non-Transferable Processes During Lifecycle Optimization Process optimization in pharmaceutical manufacturing is a nuanced challenge that often brings to light several critical aspects that must be managed effectively.…

Mitigating Yield Loss in Optimization During Validation Planning: A Robust Framework for Process Improvement Yield loss in pharmaceutical manufacturing during optimization and validation planning is a persistent issue that can…

Dealing with Inadequate Justification of Design Space in Regulatory Submissions In the pharmaceutical industry, the regulatory scrutiny during submissions can be a critical juncture in the journey from formulation development…

Preventing Validation Failures: Managing Process Transfer Issues During Pilot Scale In pharmaceutical manufacturing, transferring processes from pilot scale to full production is a critical juncture that can significantly affect product…

Managing Non-Transferable Processes During Validation: An ICH Q8/Q11 Playbook In the realm of pharmaceutical manufacturing, the alignment of development processes during validation can be a significant challenge. This issue often…

Addressing Excessive Process Variability During Lifecycle Optimization: A Practical Playbook In the pharmaceutical industry, process variability can pose significant challenges during the lifecycle optimization of drug products. When variability exceeds…

Framework for Improving Process Robustness When CPPs Are Not Well Defined In pharmaceutical manufacturing, poorly defined Critical Process Parameters (CPPs) during development studies can significantly hinder process robustness and regulatory…

Improving Process Robustness for Inadequate Control Strategies during Pilot Scale In the landscape of pharmaceutical manufacturing, the transition from lab-scale to pilot-scale production often uncovers inadequacies in control strategies. This…

A Practical Playbook for Addressing Process Variability During Regulatory Submissions Process variability exceeding established limits can hinder regulatory approvals and increase the risk associated with product launches. This variability can…